Can a female patient of reproductive age using Nexprolon (etonogestrel) inserts for birth control experience heavy menstrual cycles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heavy Menstrual Cycles with Nexplanon (Etonogestrel) Implants

Yes, heavy menstrual cycles can occur with Nexplanon, but they are uncommon—most users experience reduced bleeding or amenorrhea over time, with the majority having light bleeding or spotting that decreases with continued use.

Expected Bleeding Patterns with Nexplanon

  • Unscheduled spotting or light bleeding is expected during the first 3-6 months of Nexplanon use and is generally not harmful, decreasing with continued use 1.

  • Approximately 64% of users report amenorrhea or infrequent bleeding over the first 2 years, while only 15% experience frequent or prolonged bleeding 1.

  • Total menstrual blood loss typically decreases by more than 50% during the first 6 months compared to pre-treatment cycles, though individual variation exists 2.

  • Heavy or prolonged bleeding is uncommon during Nexplanon use 1.

When Heavy Bleeding Occurs: Evaluation

Before treating heavy bleeding with Nexplanon, you must rule out underlying pathology:

  • Exclude pregnancy, sexually transmitted infections (particularly in reproductive-aged women), and new pathologic uterine conditions such as polyps or fibroids 1, 3, 4.

  • Consider implant displacement as a potential cause 1.

  • Assess for medication interactions that could affect bleeding patterns 4.

Management of Heavy Bleeding with Nexplanon

If heavy bleeding occurs and underlying pathology is excluded:

  • First-line treatment: NSAIDs for 5-7 days during bleeding episodes to acutely reduce blood flow 3, 4.

  • Provide reassurance and enhanced counseling about expected bleeding patterns, as this reduces discontinuation rates 1, 3.

  • If bleeding persists beyond 3-6 months and remains unacceptable to the patient despite treatment, counsel on alternative contraceptive methods and offer another method if desired 1, 3.

Important Counseling Points

  • Counsel patients before insertion about potential changes in bleeding patterns, emphasizing that irregular bleeding in the first 3-6 months is normal and not harmful 1, 3.

  • Reassure patients that bleeding generally decreases over time, with many women experiencing only light menstrual bleeding or amenorrhea 1.

  • The experience in the first 3 months may help predict future bleeding patterns, though individual variation is highly variable 1.

Common Pitfall to Avoid

The most common reason for early discontinuation of Nexplanon is abnormal uterine bleeding, with more than half of users in observational studies discontinuing before 24 months due to bleeding concerns 1. This highlights the critical importance of pre-insertion counseling about expected bleeding changes to improve continuation rates and patient satisfaction.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Prolonged Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Heavy Menstrual Bleeding in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.